Kenvue Inc (KVUE) PT Lowered to $22 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Kenvue Inc (KVUE) PT Lowered to $22 at Barclays
July 15, 2025 2:46 AM EDTBarclays analyst Lauren Lieberman lowered the price target on Kenvue Inc (NYSE: KVUE) to $22.00 (from $23.00) while maintaining a Equalweight rating.... More
Goldman Sachs Reiterates Neutral Rating on Kenvue Inc (KVUE)
July 14, 2025 9:12 AM EDTGoldman Sachs analyst Bonnie Herzog reiterated a Neutral rating and $22.00 price target on Kenvue Inc (NYSE: KVUE).
The analyst comments "Our View -- KVUE announced this morning that CEO Mr. Thibaut Mongon has left the firm and Mr. Kirk Perry (who currently sits on KVUE's Board) has been appointed as Interim CEO, effective immediately. KVUE also reported prelim Q2 results, which were meaningfully below consensus... More
Citi on Kenvue Inc (KVUE): 'We expect a positive reaction today to the news'
July 14, 2025 8:18 AM EDTCiti analyst Filippo Falorni reiterated a Neutral rating and $24.50 price target on Kenvue Inc (NYSE: KVUE).
The analyst comments "This morning KVUE announced CEO Thibaut Mongon has departed the company and stepped down from the board, with Kirk Perry named interim KVUE CEO... More
Tylenol maker Kenvue ousts CEO amid board's strategic review
July 14, 2025 6:57 AM EDTBy Sriparna Roy and Abigail Summerville
(Reuters) -Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the entire company or pieces of it.Â
Kenvue also said that an ongoing review of strategic alternatives is advancing. The company has been seen as an acquisition target this year as it faced mounting investor pressure to boost performance or consider a sale.Â
Kenvue named director Kirk Perry as interim CEO, while Mongon also stepped down from... More
Kenvue appoints Kirk Perry as interim CEO, reviews strategic alternatives
July 14, 2025 6:46 AM EDTKenvue Inc. (NYSE: KVUE) announced that its board of directors appointed Kirk Perry as interim chief executive officer, effective immediately, while the company reviews strategic alternatives to unlock shareholder value.
Perry, a current Kenvue director with over 30 years of consumer products experience, replaces Thibaut Mongon, who... More



